耐苯唑西林金黄色葡萄球菌对氨苯砜、磺胺甲恶唑单独及与甲氧苄啶联合使用时的体外药敏情况。
In vitro susceptibilities of oxacillin-resistant Staphylococcus aureus to dapsone and sulfamethoxazole alone and in combination with trimethoprim.
作者信息
Lambertus M W, Kwok R Y, Mulligan M E
机构信息
Medical Service, Sepulveda Veterans Affairs Medical Center, California 91343.
出版信息
Antimicrob Agents Chemother. 1990 Jul;34(7):1453-5. doi: 10.1128/AAC.34.7.1453.
Abstract
The in vitro activity of trimethoprim plus dapsone against oxacillin-resistant Staphylococcus aureus was comparable to that of trimethoprim plus sulfamethoxazole. Because of its different pharmacologic properties, dapsone may be a useful agent in combination with trimethoprim for the treatment of patients colonized with oxacillin-resistant S. aureus.
摘要
甲氧苄啶加氨苯砜对耐苯唑西林金黄色葡萄球菌的体外活性与甲氧苄啶加磺胺甲恶唑相当。由于其药理特性不同，氨苯砜可能是与甲氧苄啶联合用于治疗耐苯唑西林金黄色葡萄球菌定植患者的有用药物。
相似文献
1
In vitro susceptibilities of oxacillin-resistant Staphylococcus aureus to dapsone and sulfamethoxazole alone and in combination with trimethoprim.
Antimicrob Agents Chemother. 1990 Jul;34(7):1453-5. doi: 10.1128/AAC.34.7.1453.
2
Failure of rapid agglutination methods to detect oxacillin-resistant Staphylococcus aureus.
J Clin Microbiol. 1986 Sep;24(3):490-2. doi: 10.1128/jcm.24.3.490-492.1986.
3
Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
J Clin Microbiol. 1984 Oct;20(4):817-9. doi: 10.1128/jcm.20.4.817-819.1984.
4
[Development of bacterial resistance against trimethoprim-sulfamethoxazole (Eusaprim)].
Fortschr Med. 1974 Jan 24;92(3):121-6.
5
In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 1986 Jun;29(6):1092-4. doi: 10.1128/AAC.29.6.1092.
6
[Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Dtsch Med Wochenschr. 1992 Dec 11;117(50):1907-12. doi: 10.1055/s-2008-1062528.
7
Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus, and Streptococcus faecalis.
J Clin Pathol. 1973 Mar;26(3):175-80. doi: 10.1136/jcp.26.3.175.
8
[In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
Pathol Biol (Paris). 1983 May;31(5):429-33.
9
[Comparative susceptibility testing to sulfamethoxazole and trimethoprim by agar diffusion test on different media (author's transl)].
Immun Infekt. 1978 Dec;6(6):223-5.
10
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to sulfamethoxazole and trimethoprim.
J Infect Dis. 1973 Nov;128:Suppl:543-4 p. doi: 10.1093/infdis/128.supplement_3.s543.
引用本文的文献
1
Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone.
Antimicrob Agents Chemother. 1996 Jun;40(6):1376-81. doi: 10.1128/AAC.40.6.1376.
本文引用的文献
1
Preferential uptake of sulphone by affected skin tissue of leprosy patients as detected by a tracer method.
Nature. 1956 Oct 13;178(4537):799-800. doi: 10.1038/178799b0.
2
The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit.
Ann Intern Med. 1982 Sep;97(3):297-308. doi: 10.7326/0003-4819-97-3-297.
3
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002.
4
A review of therapeutic and hemolytic effects of dapsone.
Arch Intern Med. 1967 Aug;120(2):242-8.
5
Studies on the in vitro development of drug resistance of Proteeae to sulfonamides, trimethoprim and combinations of a sulfonamide and trimethoprim.
Chemotherapy. 1977;23(5):309-13. doi: 10.1159/000222000.
Zotero 插件